Parkside Financial Bank & Trust Neogenomics Inc Transaction History

Parkside Financial Bank & Trust

$702 Million
Q3 2024

A detailed history of Parkside Financial Bank & Trust transactions in Neogenomics Inc stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 17 shares of NEO stock, worth $278. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 17 -0.0%

Holding current value

$278

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	BUY	$11.67 - $20.73 $81 - $145	7 Added 70.0%	17 $0
Q3 2023 Nov 13, 2023	SELL	$12.15 - $17.85 $72 - $107	-6 Reduced 37.5%	10 $0
Q2 2023 Aug 15, 2023	SELL	$14.1 - $19.83 $2,679 - $3,767	-190 Reduced 92.23%	16 $0
Q1 2023 May 04, 2023	BUY	$9.09 - $19.45 $554 - $1,186	61 Added 42.07%	206 $3,000
Q4 2022 Feb 13, 2023	SELL	$6.45 - $12.07 $4,644 - $8,690	-720 Reduced 83.24%	145 $1,000
Q3 2022 Nov 01, 2022	SELL	$7.86 - $12.91 $337 - $555	-43 Reduced 4.74%	865 $7,000
Q2 2022 Jul 13, 2022	BUY	$7.06 - $13.97 $2,894 - $5,727	410 Added 82.33%	908 $7,000
Q1 2022 May 13, 2022	BUY	$12.15 - $35.28 $3,912 - $11,360	322 Added 182.95%	498 $6,000
Q4 2021 Feb 14, 2022	SELL	$30.49 - $48.49 $5,915 - $9,407	-194 Reduced 52.43%	176 $6,000
Q3 2021 Oct 29, 2021	BUY	$41.66 - $52.52 $1,666 - $2,100	40 Added 12.12%	370 $18,000
Q2 2021 Aug 06, 2021	BUY	$36.62 - $51.69 $1,061 - $1,499	29 Added 9.63%	330 $15,000
Q4 2020 Feb 09, 2021	BUY	$36.08 - $56.47 $6,638 - $10,390	184 Added 157.26%	301 $16,000
Q3 2020 Nov 06, 2020	BUY	$33.26 - $40.48 $465 - $566	14 Added 13.59%	117 $4,000
Q1 2019 May 01, 2019	BUY	$12.14 - $20.46 $1,250 - $2,107	103 New	103 $2,000

Others Institutions Holding NEO

# of Institutions

295

Shares Held

125M

Call Options Held

698K

Put Options Held

120K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.06B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Financial Bank & Trust with notifications on news.

Account

Parkside Financial Bank & Trust Neogenomics Inc Transaction History